PODD insider ownership: who sold, why, and what they still hold

Who	Shares	Price	% of total stake	Total stake after	Trade date	Filed
Flavia Pease EVP & CFO	1,882	$130.79	9.8%	17K	Oct 1, 2026	Oct 5, 2026

What stands out

Four insiders bought shares: Ashley McEvoy (5.4K shares, $1.2M), Timothy Stonesifer (3.8K shares, $700K) and Michael Minogue (2K shares, $500K), plus 1 more.Ashley McEvoy: purchase, Feb 20, 2026 · Timothy Stonesifer: purchase, Jun 3, 2026 · Michael Minogue: purchase, Feb 25, 2026

Luciana Borio sold 418 shares (14% of starting holdings), but 1.7K more vested, so the stake grew (from 3.1K to 4.3K).Largest sale, Jun 3, 2026

Tax withholding outweighed market sales: the company withheld $3.0M of officers' and directors' shares for taxes, against $602K sold on the open market. The largest was Eric Benjamin ($1.0M withheld).Largest withholding, Feb 12, 2026

Percentages cover 19 of 21 officers and directors. Left out: Robert Huffines and Jonathan Mazelsky (held no vested shares at the start). Disclosed company stock is not an insider's whole wealth.

Who sold, and how much of their stake

Officers and directors, past 12 months. Each bar is 100% of that person's own stake; not comparable between people. The stake is the vested shares held at the start of the period (Oct 9, 2025); the gold part is what they sold.

SoldRest of starting stake

Wayne Frederick

Director

46% · $543KNo plan disclosed

Luciana Borio

Director

14% · $60KNo plan disclosed

Amounts, filings and trading plans for each seller

Selling by month

Officers and directors, Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

No plan disclosedOne dollar scale for every month; the tallest bar is labeled

Common questions

Is the Insulet Corporation CEO selling stock?

No. James Hollingshead reported no open-market sales in the past 12 months.

Why are Insulet Corporation insiders selling?

Filings rarely give a reason, and we don't guess at one. What they show is how the sales were made: 0% of sales by value ran under 10b5-1 trading plans disclosed in the filings and 100% had no disclosed plan. A trading plan schedules sales in advance.

Are any Insulet Corporation insiders buying?

Yes. 4 officers or directors reported 6 purchases in the past 12 months (Form 4 code P, which includes private purchases).

How much of their stake did Insulet Corporation insiders sell?

About 0.9% overall. As a group they ended with more shares than they started with. The biggest individual seller, Wayne Frederick, gave up 46% of starting holdings. That covers the 12 months to Oct 9, 2026 and counts vested shares reported on SEC Forms 3, 4 and 5, which is not an insider's whole wealth.

The evidence

Who sold2 officers and directors: amount, % of holdings, trading plan

Who sold	Amount	% of holdings	Trading plan
Wayne Frederick Director	$543K 1.9K shares	46%	No plan disclosed
Luciana Borio Director	$60K 418 shares	14%	No plan disclosed

The full ownership picture21 of 21 insiders fully reconciled · 21 officers and directors

Vested shares across all share classes, held directly and through trusts, LLCs and family members, as reported on SEC Forms 3, 4 and 5. Unvested awards and options are never counted as owned shares.

Insider

Held Oct 9, 2025

Sold

Held Oct 9, 2026

Still held

James Hollingshead

Former President and CEO

61K

no sales

Vesting, gifts, unvested awards and holding lines for James Hollingshead

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	61,247	61,247

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
29,475	$166.62	Feb 27, 2034	$0
19,458	$266.68	Feb 25, 2035	$0

Estimate: options held × ($147.47 − strike price), using the most recent insider trade price on Form 4 (Aug 21, 2026), not a market close.

Timothy Scannell

Includes unvested RSUs, amount not disclosed.

Director

31K

33K

no sales

Vesting, gifts, unvested awards and holding lines for Timothy Scannell

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct includes unvested RSUs, amount not disclosed	Common Stock	31,364	33,024

Jessica Hopfield

Includes unvested RSUs, amount not disclosed.

Director

28K

29K

no sales

Vesting, gifts, unvested awards and holding lines for Jessica Hopfield

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct includes unvested RSUs, amount not disclosed	Common Stock	27,695	29,355

John Kapples

SVP and General Counsel

23K

28K

no sales

Vesting, gifts, unvested awards and holding lines for John Kapples

0shares vested or exercised

0gifted (net of own trusts)

−2.8Kwithheld by the company for taxes

none reportedunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	23,180	27,514

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
6,649	$166.62	Feb 27, 2034	$0
4,508	$266.68	Feb 25, 2035	$0
4,907	$245.25	Feb 24, 2036	$0

Estimate: options held × ($147.47 − strike price), using the most recent insider trade price on Form 4 (Aug 21, 2026), not a market close.

Eric Benjamin

Includes unvested RSUs, amount not disclosed.

EVP and COO

17K

24K

no sales

Vesting, gifts, unvested awards and holding lines for Eric Benjamin

0shares vested or exercised

0gifted (net of own trusts)

−4.2Kwithheld by the company for taxes

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct includes unvested RSUs, amount not disclosed	Common Stock	16,736	23,600

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
10,423	$166.62	Feb 27, 2034	$0
6,763	$266.68	Feb 25, 2035	$0
9,946	$245.25	Feb 24, 2036	$0

Estimate: options held × ($147.47 − strike price), using the most recent insider trade price on Form 4 (Aug 21, 2026), not a market close.

Michael Minogue

Includes unvested RSUs, amount not disclosed.

Director

16K

20K

no sales

Vesting, gifts, unvested awards and holding lines for Michael Minogue

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct includes unvested RSUs, amount not disclosed	Common Stock	778	2,438
Trust	Common Stock	15,453	17,483

Flavia Pease

Minor difference of 80 shares. Difference is stated in footnotes (unreported vesting, exempt acquisition or transfer).

EVP & CFO

15K

17K

no sales

Vesting, gifts, unvested awards and holding lines for Flavia Pease

0shares vested or exercised

0gifted (net of own trusts)

−1.9Kwithheld by the company for taxes

none reportedunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	15,337	17,357

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
1,641	$305.98	Oct 1, 2035	$0
9,946	$245.25	Feb 24, 2036	$0

Estimate: options held × ($147.47 − strike price), using the most recent insider trade price on Form 4 (Aug 21, 2026), not a market close.

Reconciliation: minor difference of 80 shares. Difference is stated in footnotes (unreported vesting, exempt acquisition or transfer).

Ana Chadwick

EVP, CFO & Treasurer

14K

no sales

Vesting, gifts, unvested awards and holding lines for Ana Chadwick

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	14,263	14,263

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
6,525	$266.68	Feb 25, 2035	$0

Estimate: options held × ($147.47 − strike price), using the most recent insider trade price on Form 4 (Aug 21, 2026), not a market close.

Ashley McEvoy

Minor difference of 156 shares. Difference is stated in footnotes (unreported vesting, exempt acquisition or transfer).

President and CEO, Director

9.5K

24K

no sales

Vesting, gifts, unvested awards and holding lines for Ashley McEvoy

0shares vested or exercised

0gifted (net of own trusts)

−1.4Kwithheld by the company for taxes

none reportedunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	9,540	23,731
Trust	Common Stock	4	4

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
24,150	$314.46	May 13, 2035	$0
26,143	$245.25	Feb 24, 2036	$0

Estimate: options held × ($147.47 − strike price), using the most recent insider trade price on Form 4 (Aug 21, 2026), not a market close.

Reconciliation: minor difference of 156 shares. Difference is stated in footnotes (unreported vesting, exempt acquisition or transfer).

Dan Manea

SVP, Chief HR Officer

9.1K

no sales

Vesting, gifts, unvested awards and holding lines for Dan Manea

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	9,090	9,090

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
5,390	$166.62	Feb 27, 2034	$0
3,559	$266.68	Feb 25, 2035	$0

Estimate: options held × ($147.47 − strike price), using the most recent insider trade price on Form 4 (Aug 21, 2026), not a market close.

Lauren Budden

Minor difference of 86 shares. Difference is stated in footnotes (unreported vesting, exempt acquisition or transfer).

Group VP, CAO and Controller

6.9K

8.5K

no sales

Vesting, gifts, unvested awards and holding lines for Lauren Budden

0shares vested or exercised

0gifted (net of own trusts)

−895withheld by the company for taxes

none reportedunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	6,916	8,526

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
2,874	$166.62	Feb 27, 2034	$0
1,423	$266.68	Feb 25, 2035	$0
1,591	$245.25	Feb 24, 2036	$0

Estimate: options held × ($147.47 − strike price), using the most recent insider trade price on Form 4 (Aug 21, 2026), not a market close.

Reconciliation: minor difference of 86 shares. Difference is stated in footnotes (unreported vesting, exempt acquisition or transfer).

Elizabeth Weatherman

Director

5.2K

10K

no sales

Vesting, gifts, unvested awards and holding lines for Elizabeth Weatherman

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	5,242	10,352

Wayne Frederick

Director

−1.9K

3.8K

95%

Vesting, gifts, unvested awards and holding lines for Wayne Frederick

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	4,009	3,818

Laetitia Cousin

SVP, Reg, Quality & Compliance

3.9K

5.7K

no sales

Vesting, gifts, unvested awards and holding lines for Laetitia Cousin

0shares vested or exercised

0gifted (net of own trusts)

−1.1Kwithheld by the company for taxes

none reportedunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	3,890	5,674

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
542	$276.36	Feb 28, 2033	$0
3,876	$166.62	Feb 27, 2034	$0
2,432	$266.68	Feb 25, 2035	$0
2,718	$245.25	Feb 24, 2036	$0

Estimate: options held × ($147.47 − strike price), using the most recent insider trade price on Form 4 (Aug 21, 2026), not a market close.

Timothy Stonesifer

Director

3.6K

no sales

Vesting, gifts, unvested awards and holding lines for Timothy Stonesifer

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	3,629	9,041

Prem Singh

Minor difference of 31 shares. Difference is stated in footnotes (unreported vesting, exempt acquisition or transfer).

SVP, Global Operations

3.5K

6.9K

no sales

Vesting, gifts, unvested awards and holding lines for Prem Singh

0shares vested or exercised

0gifted (net of own trusts)

−1.3Kwithheld by the company for taxes

none reportedunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	3,456	6,891

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
759	$276.36	Feb 28, 2033	$0
195	$264.69	Feb 28, 2032	$0
3,774	$166.62	Feb 27, 2034	$0
3,559	$266.68	Feb 25, 2035	$0
5,570	$245.25	Feb 24, 2036	$0

Estimate: options held × ($147.47 − strike price), using the most recent insider trade price on Form 4 (Aug 21, 2026), not a market close.

Reconciliation: minor difference of 31 shares. Difference is stated in footnotes (unreported vesting, exempt acquisition or transfer).

Luciana Borio

Director

3.1K

−418

4.3K

+40%

Vesting, gifts, unvested awards and holding lines for Luciana Borio

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	3,087	4,329

Lisa Davis

Minor difference of 80 shares. Difference is stated in footnotes (unreported vesting, exempt acquisition or transfer).

SVP, Chief HR Officer

2.5K

4.5K

no sales

Vesting, gifts, unvested awards and holding lines for Lisa Davis

0shares vested or exercised

0gifted (net of own trusts)

−244withheld by the company for taxes

none reportedunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	2,477	4,453

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
1,869	$284.91	Aug 1, 2035	$0
5,570	$245.25	Feb 24, 2036	$0

Estimate: options held × ($147.47 − strike price), using the most recent insider trade price on Form 4 (Aug 21, 2026), not a market close.

Reconciliation: minor difference of 80 shares. Difference is stated in footnotes (unreported vesting, exempt acquisition or transfer).

Michael Panos

Started reporting during the period; starting holdings are from the Form 3.

EVP and CCO

2.8K

no sales

Vesting, gifts, unvested awards and holding lines for Michael Panos

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Started reporting during the period; starting holdings are from the Form 3.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	5	2,782

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
7,255	$207.04	Apr 1, 2036	$0

Estimate: options held × ($147.47 − strike price), using the most recent insider trade price on Form 4 (Aug 21, 2026), not a market close.

Robert Huffines

Minor difference of -1 share. Difference is under 0.5% of holdings. Started reporting during the period; starting holdings are from the Form 3.

Director

2.6K

no sales

Vesting, gifts, unvested awards and holding lines for Robert Huffines

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Started reporting during the period; starting holdings are from the Form 3.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	0	2,627

Reconciliation: minor difference of -1 share. Difference is under 0.5% of holdings.

Jonathan Mazelsky

Started reporting during the period; starting holdings are from the Form 3.

Director

1.5K

no sales

Vesting, gifts, unvested awards and holding lines for Jonathan Mazelsky

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Started reporting during the period; starting holdings are from the Form 3.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	0	1,496

21 of 21 insiders fully reconciled: starting holdings plus reported transactions match ending holdings (15 exactly, 6 with a minor or footnoted difference). Percentages cover 19 of 21 officers and directors. Left out: Robert Huffines and Jonathan Mazelsky (held no vested shares at the start). "Still held" compares ending with starting vested shares; a plus sign means the holding grew.

What explains the selling$602K of sales by plan status, purpose, seller and month

Officer and director open-market sales: $602K across 2,269 shares. Plan status and stated purpose are separate questions, and a sale can have both.

By plan status

No plan disclosed · $602K

Sales with no 10b5-1 plan and no tax reference in the filing. $543K of it is Wayne Frederick. No plan disclosed is a statement about the filing, not about why the sale happened. Largest such sale: Wayne Frederick, Dec 15, 2025

Taxes

13,759 shares ($3.0M) were withheld by the company for taxes, which isn't a market sale.

Purchases · 4 buyers (6 trades)

4 officers and directors bought shares in this period, in 6 trades(Form 4 code P). Across all their filings on record there are 13 purchase trades.

Seller	Shares sold	Proceeds	Under a disclosed plan	Share of total	Sales dates
Wayne Frederick Director	1.9K	$543K	0%	90%	Dec 15, 2025 to Dec 15, 2025
Luciana Borio Director	418	$60K	0%	10%	Jun 3, 2026 to Jun 3, 2026

Sales by month

Month	Sale proceeds	Disclosed plan	To cover taxes	No plan disclosed
Oct 2025	$0	$0	$0	$0
Nov 2025	$0	$0	$0	$0
Dec 2025	$543K	$0	$0	$543K
Jan 2026	$0	$0	$0	$0
Feb 2026	$0	$0	$0	$0
Mar 2026	$0	$0	$0	$0
Apr 2026	$0	$0	$0	$0
May 2026	$0	$0	$0	$0
Jun 2026	$60K	$0	$0	$60K
Jul 2026	$0	$0	$0	$0
Aug 2026	$0	$0	$0	$0
Sep 2026	$0	$0	$0	$0
Oct 2026	$0	$0	$0	$0

Is this normal? Selling year by year5 earlier years to compare with

Less than usual: less than one-twentieth of the 5-year average. 2 insiders sold; the average is 7 a year.

12 months ending	Shares sold	Insiders who sold	Proceeds
Oct 9, 2026 Latest 12 months	2.3K	2	$602K
Oct 9, 2025 1 year earlier	45K	9	$13.4M
Oct 9, 2024 2 years earlier	80K	7	$14.5M
Oct 10, 2023 3 years earlier	98K	7	$28.4M
Oct 10, 2022 4 years earlier	77K	5	$19.3M
Oct 10, 2021 5 years earlier	97K	7	$26.0M

Open-market sales (Form 4 code S) by people who were officers or directors, in split-adjusted shares. Earlier years include people who have since left. A sale that an outside holder also reports (a family trust, a fund) is counted with outside holders in every year. Shares, not dollars, are compared, so a change in the stock price doesn't look like a change in selling. Years the filings don't fully cover are shown but left out of the average.

Known gaps and uncertaintyEvery officer and director reconciles

Every officer and director reconciles for this period.

Flavia Pease: minor difference of 80 shares. Difference is stated in footnotes (unreported vesting, exempt acquisition or transfer).

Ashley McEvoy: minor difference of 156 shares. Difference is stated in footnotes (unreported vesting, exempt acquisition or transfer).

Lauren Budden: minor difference of 86 shares. Difference is stated in footnotes (unreported vesting, exempt acquisition or transfer).

Prem Singh: minor difference of 31 shares. Difference is stated in footnotes (unreported vesting, exempt acquisition or transfer).

Lisa Davis: minor difference of 80 shares. Difference is stated in footnotes (unreported vesting, exempt acquisition or transfer).

Robert Huffines: minor difference of -1 share. Difference is under 0.5% of holdings.

Inferred rename: "Reporting Person disclaims beneficial ownership" is treated as the same holder as "Caduceus Private Investments II, LP", because the old name was never reported again and the new one opened with the same balance (1,568,841 shares). Old name, new name

Inferred rename: "Trust" is treated as the same holder as "NG Trust", because the old name was never reported again and the new one opened with the same balance (87,495 shares). Old name, new name

External context: we only cite outside events when a documented connection exists. None is shown for this period.

Sources and methodology1,054 filings from SEC EDGAR, and how we read them

All 1,054 Forms 3, 4 and 5 filed for Insulet Corporation (SEC CIK 1145197) from May 14, 2007 to Oct 5, 2026, retrieved from SEC EDGAR on Oct 9, 2026. Prices are the ones reported in each filing, often weighted averages.

Holdings. Each holding line (a share class plus an owner, such as a trust or LLC) carries its last reported balance forward. Entities first reported during the period start at zero, so transfers between an insider's own trusts don't count as selling. Lines not reported for three years or more are listed separately and left out of totals.

Sales. A sale counts as under a 10b5-1 plan if its footnote cites one or the filing's Rule 10b5-1 box is checked, and as tax-related if its footnote cites tax obligations or sell-to-cover. Shares withheld by the company for taxes are listed separately. Sales with neither attribute are labeled "no plan disclosed".

Full methodology

Former or inactive filers (55)No filing in 18 months; last reported balances, not in any total

Name	Last filed	Last reported balance
Mark Field	Mar 4, 2025	13,411 shares, last reported balance as of Feb 28, 2025
Shacey Petrovic	Feb 29, 2024	32,567 shares, last reported balance as of Feb 28, 2024
Wayde McMillan	Jul 6, 2023	21,477 shares, last reported balance as of Jul 3, 2023
Corinne Nevinny	May 24, 2023	6,010 shares, last reported balance as of May 23, 2023
Charles Alpuche	Mar 15, 2023	56,954 shares, last reported balance as of Mar 14, 2023
Michael Spears	Mar 13, 2023	13,645 shares, last reported balance as of Mar 9, 2023
Bret Christensen	Mar 1, 2023	20,178 shares, last reported balance as of Feb 28, 2023
David Lemoine	Nov 12, 2021	10,756 shares, last reported balance as of Nov 11, 2021
Sally Crawford	Jun 7, 2021	20,306 shares, last reported balance as of Jun 4, 2021
John Fallon	May 25, 2021	14,498 shares, last reported balance as of May 21, 2021
David Colleran	Apr 4, 2019	27,200 shares, last reported balance as of Apr 2, 2019
Aiman Abdel-Malek	Apr 1, 2019	16,454 shares, last reported balance as of Mar 28, 2019
Michael Levitz	Feb 28, 2019	51,802 shares, last reported balance as of Feb 27, 2019
James Mullen	May 18, 2018	4,685 shares, last reported balance as of May 16, 2018
Patrick Sullivan	Apr 2, 2018	261,479 shares, last reported balance as of Mar 29, 2018
Bradley Thomas	Apr 2, 2018	47,209 shares, last reported balance as of Mar 29, 2018
Regina Sommer	May 18, 2017	22,029 shares, last reported balance as of May 17, 2017
Joseph Zakrzewski	May 18, 2017	29,548 shares, last reported balance as of May 17, 2017
Daniel Levangie	May 2, 2016	13,563 shares, last reported balance as of Apr 30, 2016
Steven Sobieski	May 18, 2015	13,039 shares, last reported balance as of May 13, 2015
Anthony Diehl	May 13, 2015	10,017 shares, last reported balance as of May 11, 2015
Patrick Ryan	May 6, 2015	9,436 shares, last reported balance as of May 5, 2015
Charles Liamos	Apr 3, 2015	49,575 shares, last reported balance as of Apr 1, 2015
Allison Dorval	Apr 3, 2015	13,328 shares, last reported balance as of Apr 1, 2015
Kathleen Hayes	Sep 30, 2014	1,346 shares, last reported balance as of Sep 19, 2014
Duane DeSisto	Sep 4, 2014	93,184 shares, last reported balance as of Sep 2, 2014
Peter Devlin	Jun 10, 2014	22,420 shares, last reported balance as of Jun 9, 2014
Brian Roberts	Apr 3, 2014	72,050 shares, last reported balance as of Apr 1, 2014
Tracey Wielinski	Mar 7, 2014	No balance on record
Mark Lortz	Jun 5, 2013	4,000 shares, last reported balance as of Jun 3, 2013
Ruthann DePietro	Sep 6, 2012	2,350 shares, last reported balance as of Sep 4, 2012
Ross Jaffe	Feb 22, 2012	18,520 shares, last reported balance as of Feb 16, 2012
Ross Jaffe	Feb 22, 2012	1,320,531 shares, last reported balance as of Feb 22, 2012
Carsten Boess	Apr 27, 2011	2,274 shares, last reported balance as of Apr 25, 2011
Luis Malave	Mar 3, 2010	195,857 shares, last reported balance as of Mar 1, 2010
Robert Campbell	Jan 27, 2010	63,633 shares, last reported balance as of Jan 25, 2010
Gary Eichhorn	Apr 21, 2009	70,749 shares, last reported balance as of Apr 20, 2009
John Garibotto	Mar 2, 2009	72,980 shares, last reported balance as of May 14, 2007
Shawna Gvazdauskas	Mar 2, 2009	No balance on record
Kevin Schmid	Mar 2, 2009	17,500 shares, last reported balance as of Mar 18, 2008
Lars Boesgaard	Mar 2, 2009	No balance on record
Jason Ng	Mar 2, 2009	No balance on record
William Arthur III	Mar 2, 2009	No balance on record
David Howe	Mar 2, 2009	No balance on record
de Peyromaure	May 12, 2008	1,192,453 shares, last reported balance as of Nov 13, 2007
Andrew Suchoff	Mar 31, 2008	No balance on record
Jefferey Smith	Mar 14, 2008	No balance on record
PRISM VENTURE PARTNERS III LP	Feb 13, 2008	2,168,640 shares, last reported balance as of May 18, 2007
Gordon Nye	Feb 7, 2008	2,168,640 shares, last reported balance as of May 18, 2007
Stephen Bubrick	Aug 10, 2007	No balance on record
PEQUOT CAPITAL MANAGEMENT INC	May 22, 2007	2,134,289 shares, last reported balance as of May 18, 2007
ORBIMED ADVISORS LLC	May 18, 2007	3,137,682 shares, last reported balance as of May 18, 2007
Jonathan Silverstein	May 18, 2007	1,568,841 shares, last reported balance as of May 18, 2007
VERSANT VENTURE CAPITAL I LP	May 17, 2007	2,127,943 shares, last reported balance as of May 14, 2007
Samuel Colella	May 17, 2007	2,127,943 shares, last reported balance as of May 14, 2007

Spotted something wrong on this page? Report an error. We check every report against the SEC filing and list what we fix in the corrections log.

Insulet Corporation insiders sold $602K in the past 12 months. How much of their stake is that?

What stands out

Who sold, and how much of their stake

Selling by month

Common questions

Is the Insulet Corporation CEO selling stock?

Why are Insulet Corporation insiders selling?

Are any Insulet Corporation insiders buying?

How much of their stake did Insulet Corporation insiders sell?

The evidence

No plan disclosed · $602K

Taxes

Purchases · 4 buyers (6 trades)

Sales by month